Antigen-specific B cell detection reagents: Use and quality control

Cytometry Part A

Volumn 73, Issue 11, 2008, Pages 1086-1092

  Moody, M Anthony ^a   Haynes, Barton F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antibodies; B cells; HIV 1 envelope; Tetramers

Indexed keywords

ANTIGEN; B LYMPHOCYTE RECEPTOR; REAGENT;

ANTIBODY PRODUCTION; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; B LYMPHOCYTE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; REVIEW; VIRUS ENVELOPE;

ANTIGENS; B-LYMPHOCYTES; EPITOPES; HUMANS; INDICATORS AND REAGENTS; QUALITY CONTROL; RECEPTORS, ANTIGEN, B-CELL;

EID: 55949112221     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20599     Document Type: Review

References (61)

1. Llewelyn MB, Hawkins RE, Russell SJ. Discovery of antibodies. BMJ 1992;305:1269-1272.
2. MacNalty AS. Emil von Behring, born March 15, 1854. BMJ 1954;1:668-670.
3. Dale H. Paul Ehrlich, born March 14, 1854. BMJ 1954;1:659-663.
4. Wasserman A, Neisser A, Bruck C. Eine serodiagnostische Reaktion bei Syphilis. Deutsche medizinische Wochenschrift 1906;32:745-746.
5. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G. Immunochemistry 1971;8:871-874.
6. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-497.
7. Bernard A, Boumsell L, Dausset J, Milstein C, Schlossman SF, editors. Leucocyte Typing: Human Leucocyte Differentiation Antigens Detected By Monoclonal Antibodies: Specification, Classification, Nomenclature. Berlin, New York: Springer-Verlag; 1984. xxiv, 814 p.
8. Reinherz EL, Haynes BF, Nadler LM, Bernstein ID, editors. Leukocyte Typing. II. Volume 2: Human B Lymphocytes. New York: Springer-Verlag; 1986. 560 p.
9. Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Disease J 2001;20:63-75.
10. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. New Engl J Med 2007;357:1903-1915.
11. Pauza CD, Trivedi P, Wallace M, Ruckwardt TJ, Le Buanec H, Lu W, Bizzini B, Burny A, Zagury D, Gallo RC. Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci USA 2000;97:3515-3519.
12. Silvera P, Richardson MW, Greenhouse J, Yalley-Ogunro J, Shaw N, Mirchandani J, Khalili K, Zagury J-F, Lewis MG, Rappaport J. Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus tat protein. J Virol 2002;76:3800-3809.
13. Baba TW, Liska V, Khimani AH, Ray NB, Dailey PJ, Penninck D, Bronson R, Greene MF, McClure HM, Martin LN, Ruprecht RM. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med 1999; 5:194-203.
14. LaCasse RA, Follis KE, Trahey M, Scarborough JD, Littman DR, Nunberg JH. Fusion-competent vaccines: Broad neutralization of primary isolates of HIV. Science 1999;283:357-362.
15. Nunberg JH. Retraction. Science 2002;296:1025.
16. Sekaly R-P. The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development? J Exp Med 2008;205:7-12.
17. Pitisuttithum P, Berman PW, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai L-O, Hirunras K, Kitayaporn D, Kaewkangwal J, Migasena S, Sheppard HW, Li E, Chernow M, Peterson ML, Shibata R, Heyward WL, Francis DP. Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1. JAIDS 2004; 37:1160-1165.
18. VanCott TC, Bethke FR, Burke DS, Redfield RR, Birx DL. Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines. J Immunol 1995;155:4100-4110.
19. Anonymous. Global situation of the HIV/AIDS epidemic, end 2004. Weekly Epidemiol Record 2004;79:441-449.
20. Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000;6:207-210.
21. Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Lu Y, Wright JE, Chou TC, Ruprecht RM. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000;6:200-206.
22. Haynes BF, Fleming J, St.Clair EW, Katinger H, Stiegler G, Kunert R, Robinson J, Scearce RM, Plonk K, Staats HF, Ortel TL, Liao HX, Alam SM. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 2005;308:1906-1908.
23. Zwick MB, Komori HK, Stanfield RL, Church S, Wang M, Parren PW, Kunert R, Katinger H, Wilson IA, Burton DR. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5. J Virol 2004;78:3155-3161.
24. Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 2005;22:163-173.
25. Saphire EO, Parren PWHI, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA. Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design. science 2001;293:1155-1159.
26. Calarese DA, Scanlan CN, Zwick MB, Deechongkit S, Mimura Y, Kunert R, Zhu P, Wormald MR, Stanfield RL, Roux KH, Kelly JW, Rudd PM, Dwek RA, Katinger H, Burton DR, Wilson IA. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 2003;300:2065-2071.
27. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM. Antibody neutralization and escape by HIV-1. Nature 2003;422:307-312.
28. Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, Steenbeke TD, Venturi M, Chaiken I, Fung M, Katinger H, Parren PW, Robinson J, Van Ryk D, Wang L, Burton DR, Freire E, Wyatt R, Sodroski J, Hendrickson WA, Arthos J. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 2002;420: 678-682.
29. Eckert DM, Kim PS. Mechanisms of viral membrane fusion and its inhibition. Annual Rev Biochem 2001;70:777-810.
30. Barbato G, Bianchi E, Ingallinella P, Hurni WH, Miller MD, Ciliberto G, Cortese R, Bazzo R, Shiver JW, Pessi A. Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion. J Mol Biol 2003;330:1101-1115.
31. Ofek G, Tang M, Sambor A, Katinger H, Mascola JR, Wyatt R, Kwong PD. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 2004;78:10724-10737.
32. Sun ZY, Oh KJ, Kim M, Yu J, Brusic V, Song L, Qiao Z, Wang JH, Wagner G, Reinherz EL. HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 2008;28:52-63.
33. Zhu P, Liu J, Bess J, Jr, Chertova E, Lifson JD, Grise H, Ofek GA, Taylor KA, Roux KH. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 2006;441:847-852.
34. Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT. HIV vaccine design and the neutralizing antibody problem. Nat Immunol 2004;5:233-236.
35. Haynes BF, Moody MA, Verkoczy L, Kelsoe G, Alam SM. Antibody polyspecificity and neutralization of HIV-1: A hypothesis. Human Antibodies 2005;14:59-67.
36. Sanz I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol 1991;147:1720-1729.
37. Sedgwick JD, Holt PG. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods 1983;57:301-309.
38. Czerkinsky CC, Nilsson L-A, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibodysecreting cells. J Immunol Methods 1983;65:109-121.
39. Olive D, Autran B, Robinet E, Consortium AIB. The ELISPOT assay - Quality issues related to its use in a multicenter setting. 2008; Presented at the third MASIR conference, La Plagne, France.
40. Precopio ML, Butterfield TR, Casazza JP, Koup RA, Roederer M. Optimization of T cell epitope identification. Cytometry A 2008;73A:in press. DOI: 10.1002/cyto.a.20646 (this issue).
41. Li Pira G, Ivaldi F, Dentone C, Righi E, Del Bono V, Viscoli C, Manca F. Miniaturization and automation for measuring antigen specific T-cell responses. 2008; Presented at the third MASIR conference, La Plagne, France.
42. Tokimitsu Y, Kishi H, Kondo S, Honda R, Tajiri K, Motoki K, Ozawa T, Kadowaki S, Obata T, Fujiki S, Tateno C, Takaishi H, Chayama K, Yoshizato K, Tamiya E, Sugiyama T, Muraguchi A. Single lymphocyte analysis with a microwell array chip. Cytometry A 2007;71A:1003-1010.
43. Tajiri K, Kishi H, Tokimitsu Y, Kondo S, Ozawa T, Kinoshita K, Jin A, Kadowaki S, Sugiyama T, Muraguchi A. Cell-microarray analysis of antigen-specific B-cells: Single cell analysis of antigen receptor expression and specificity. Cytometry A 2007;71A:961-967.
44. Julius MH, Masuda T, Herzenberg LA. Demonstration that antigen-binding cells are precursors of antibody-producing cells after purification with a fluorescence-activated cell sorter. Proc Natl Acad Sci USA 1972;69:1934-1938.
45. Julius MH, Janeway CA, Jr, Herzenberg LA. Isolation of antigen-binding cells from unprimed mice. II. Evidence for monospecificity of antigen-binding cells. Eur J Immunol 1976;6:288-292.
46. Greenstein JL, Leary J, Horan P, Kappler JW, Marrack P. Flow sorting of antigenbinding B cell subsets. J Immunol 1980;124:1472-1481.
47. McHeyzer-Williams MG, Nossal GJV, Lalor PA. Molecular characterization of single memory B cells. Nature 1991;350:502-505.
48. + B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP. Eur J Immunol 1992;22:3001-3011.
49. McHeyzer-Williams LJ, Cool M, McHeyzer-Williams MG. Antigen-specific B cell memory: Expression and replenishment of a novel B220- memory B cell compartment. J Exp Med 2000;191:1149-1166.
50. Blink EJ, Light A, Kallies A, Nutt SL, Hodgkin PD, Tarlinton DM. Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med 2005;201:545-554.
51. Hoven MY, De Leij L, Keij JFK, The TH. Detection and isolation of antigen-specific B cells by the fluorescence activated cell sorter (FACS). J Immunol Methods 1989;117:275-284.
52. Hayakawa K, Ishii R, Yamasaki K, Kishimoto T, Hardy RR. Isolation of high-affinity memory B cells: Phycoerythrin as a probe for antigen-binding cells. Proc Natl Acad Sci USA 1987;84:1379-1383.
53. Doucett VP, Gerhard W, Owler K, Curry D, Brown L, Baumgarth N. Enumeration and characterization of virus-specific B cells by multicolor flow cytometry. J Immunol Methods 2005;303:40-52.
54. Newman J, Rice JS, Wang C, Harris SL, Diamond B. Identification of an antigen-specific B cell population. J Immunol Methods 2003;272:177-187.
55. Kodituwakku AP, Jessup C, Zola H, Roberton DM. Isolation of antigen-specific B cells. Immunol Cell Biolgy 2003;81:163-170.
56. Townsend SE, Goodnow CC, Cornall RJ. Single epitope multiple staining to detect ultralow frequency B cells. J Immunol Methods 2001;249:137-146.
57. Unanue ER, Perkins WD, Karnovsky MJ. Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med 1972;136:885-906.
58. Splinter TA, Collard JG, De Wildt A, Temmink JH, Décary F. Capping of surface immunoglobulin on 'hairy cells' is independent of energy production. J Cell Sci 1979;36:45-59.
59. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dörner T, Hiepe F. Competence and competition: The challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006;6:741-750.
60. Alam SM, McAdams M, Boren D, Rak M, Scearce RM, Gao F, Camacho ZT, Gewirth D, Kelsoe G, Chen P, Haynes BF. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. J Immunol 2007;178:4424-4435.
61. Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G, Ruker F, Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 1993;67:6642-6647.